Electrochemotherapy with cisplatin enhances local control after surgical ablation of fibrosarcoma in cats: An approach to improve the therapeutic index of highly toxic chemotherapy drugs

Journal of Translational Medicine

Volumn 9, Issue 1, 2011, Pages

  Spugnini, Enrico P ^a   Renaud, Sylvie M ^b   Buglioni, Sabrina ^c   Carocci, Francesca ^c   Dragonetti, Emanuele ^d   Murace, Raffaele ^d   Cardelli, Pierluigi ^e   Vincenzi, Bruno ^f   Baldi, Alfonso ^g   Citro, Gennaro ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b Ambulatorio Veterinario Renaud   (Italy)

^c Ambulatorio Veterinario Le Accademie   (Italy)

^d Futura Onlus   (Italy)

^e UNIVERSITY OF ROME TOR VERGATA   (Italy)

^f UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^g SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; ANTINEOPLASTIC AGENT;

ABLATION THERAPY; ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD TOXICITY; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER RECURRENCE; CANCER SURGERY; CAT; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ELECTROCHEMOTHERAPY; GASTROINTESTINAL TOXICITY; HEART DISEASE; INTERMETHOD COMPARISON; MUSCLE DISEASE; NEPHROTOXICITY; NONHUMAN; OUTCOME ASSESSMENT; RESPIRATORY DISTRESS; SOFT TISSUE DISEASE; SOFT TISSUE SARCOMA; TOXICITY TESTING; TREATMENT RESPONSE; ANIMAL; FIBROSARCOMA; KAPLAN MEIER METHOD; METHODOLOGY; TREATMENT OUTCOME;

ABLATION TECHNIQUES; ANIMALS; ANTINEOPLASTIC AGENTS; CATS; CISPLATIN; ELECTROCHEMOTHERAPY; FIBROSARCOMA; KAPLAN-MEIER ESTIMATE; TREATMENT OUTCOME;

EID: 80052866014     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-9-152     Document Type: Article

References (30)

1. De Souza R, Zahedi P, Allen CJ, Piquette-Miller M. Polymeric drug delivery systems for localized cancer chemotherapy. Drug Delivery 2010, 17:365-375. 10.3109/10717541003762854, 20429844.
2. Ma X, Yu H. Global burden of cancer. Yale J Biol Med 2006, 79:85-94. 1994799, 17940618.
3. Kim JJ, Tannock IF. Repopulation of cancer cells during therapy: an important cause of treatment failure. Nat Rev Cancer 2005, 5:516-525. 10.1038/nrc1650, 15965493.
4. Stavreva NA, Stavrev PV, Warkentin B, Fallone BG. Investigating the effect of cell repopulation on the tumor response to fractionated external radiotherapy. Med Phys 2003, 30:735-742. 10.1118/1.1567735, 12772979.
5. Brade AM, Tannock IF. Scheduling of radiation and chemotherapy for limited-stage small-cell lung cancer: repopulation as a cause of treatment failure?. J Clin Oncol 2006, 24:1020-1022. 10.1200/JCO.2005.04.9676, 16505418.
6. Davis AJ, Tannock JF. Repopulation of tumour cells between cycles of chemotherapy: a neglected factor. Lancet Oncol 2000, 1:86-93. 10.1016/S1470-2045(00)00019-X, 11905673.
7. Corry J, Rischin D. Strategies to overcome accelerated repopulation and hypoxia--what have we learned from clinical trials?. Semin Oncol 2004, 31:802-808. 10.1053/j.seminoncol.2004.09.005, 15599858.
8. Vassileva V, Allen CJ, Piquette-Miller M. Effects of sustained and intermittent paclitaxel therapy on tumor repopulation in ovarian cancer. Mol Cancer Ther 2008, 7:630. 10.1158/1535-7163.MCT-07-2117, 18347149.
9. Ishikawa E, Yamamoto T, Sakamoto N, Nakai K, Akutsu H, Tsuboi K, Takano S, Matsumura A. Low peripheral lymphocyte count before focal radiotherapy plus concomitant temozolomide predicts severe lymphopenia during malignant glioma treatment. Neurol Med Chir (Tokyo) 2010, 50:638-644.
10. Gasparini G. Metronomic scheduling: the future of chemotherapy?. Lancet Oncol 2001, 2:733-740. 10.1016/S1470-2045(01)00587-3, 11902515.
11. Scharovsky OG, Mainetti LE, Rozados VR. Metronomic chemotherapy: changing the paradigm that more is better. Curr Oncol 2009, 16:91-99.
12. Au JL, Jang SH, Zheng J, Chen CT, Song S, Hu L, Wientjes MG. Determinants of drug delivery and transport to solid tumors. J Control Release 2001, 74:31-46. 10.1016/S0168-3659(01)00308-X, 11489481.
13. Au JL, Jang SH, Wientjes MG. Clinical aspects of drug delivery to tumors. J Control Release 2002, 78:81-95. 10.1016/S0168-3659(01)00488-6, 11772451.
14. Jang SH, Wientjes MG, Lu D, Au JLS. Drug delivery and transport to solid tumors. Pharm Res 2003, 20:1337-1350. 10.1023/A:1025785505977, 14567626.
15. Dizon DS, Kemeny NE. Intrahepatic arterial infusion of chemotherapy: clinical results. Semin Oncol 2002, 29:126-135. 10.1053/sonc.2002.31680, 11951210.
16. Withrow SJ, Liptak JM, Straw RC, Dernell WS, Jameson VJ, Powers BE, Johnson JL, Brekke JH, Douple EB. Biodegradable cisplatin polymer in limb-sparing surgery for canine osteosarcoma. Ann Surg Oncol 2004, 11:705-713. 10.1245/ASO.2004.10.008, 15231525.
17. Liu J, Meisner D, Kwong E, Wu XY, Johnston MR. A novel trans-lymphatic drug delivery system: implantable gelatin sponge impregnated with PLGA-paclitaxel microspheres. Biomaterials 2007, 28:3236-3244. 10.1016/j.biomaterials.2007.03.022, 17434581.
18. Olson JJ, McKenzie E, Skurski-Martin M, Zhang Z, Brat D, Phuphanich S. Phase I analysis of BCNU-impregnated biodegradable polymer wafers followed by systemic interferon alfa-2b in adults with recurrent glioblastoma multiforme. J Neurooncol 2008, 90:293-299. 10.1007/s11060-008-9660-z, 18679580.
19. Spugnini EP, Porrello A. Potentiation of chemotherapy in companion animals with spontaneous large neoplasms by application of biphasic electric pulses. J Exp Clin Cancer Res 2003, 22:571-580.
20. Spugnini EP, Citro G, D'Avino A, Baldi A. Potential role of electrochemotherapy for the treatment of soft tissue sarcoma: first insights from preclinical studies in animals. Int J Biochem Cell Biol 2008, 40:159-163. 10.1016/j.biocel.2007.10.005, 17977058.
21. Spugnini EP, Citro G, Baldi A. Adjuvant electrochemotherapy in veterinary patients: a model for the planning of future therapies in humans. J Exp Clin Cancer Res 2009, 28:114. 10.1186/1756-9966-28-114, 2739846, 19682373.
22. Spugnini EP, Dragonetti E, Vincenzi B, Onori N, Citro G, Baldi A. Pulse-mediated chemotherapy enhances local control and survival in a spontaneous canine model of primary mucosal melanoma. Melanoma Res 2006, 16:23-27. 10.1097/01.cmr.0000195702.73192.a0, 16432452.
23. Spugnini EP, Baldi A, Vincenzi B, Bongiorni F, Bellelli C, Citro G, Porrello A. Intraoperative versus postoperative electrochemotherapy in high grade soft tissue sarcomas: a preliminary study in a spontaneous feline model. Cancer Chemother Pharmacol 2007, 59:375-381.
24. Spugnini EP, Baldi F, Mellone P, Feroce F, D'Avino A, Bonetto F, Vincenzi B, Citro G, Baldi A. Patterns of tumor response in canine and feline cancer patients treated with electrochemotherapy: preclinical data for the standardization of this treatment in pets and humans. J Transl Med 2007, 5:48. 10.1186/1479-5876-5-48, 2082020, 17910745.
25. Spugnini EP, Vincenzi B, Citro G, Dotsinsky I, Mudrov T, Baldi A. Evaluation of Cisplatin as an electrochemotherapy agent for the treatment of incompletely excised mast cell tumors in dogs. J Vet Intern Med 2011, 25:407-411. 10.1111/j.1939-1676.2011.0678.x, 21382075.
26. Barabas K, Milner R, Lurie D, Adin C. Cisplatin: a review of toxicities and therapeutic applications. Vet Comp Oncol 2008, 6:1-18. 10.1111/j.1476-5829.2007.00142.x, 19178659.
27. Cisplatin. Veterinary Drugs Handbook 2005, 175-177. Ames IA: Blackwell Publishing Co, Plumb DC, 5.
28. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958, 53:457-481.
29. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977, 35:1-39. 10.1038/bjc.1977.1, 2025310, 831755.
30. Sawyer AJ, Piepmeier JM, Saltzman WM. New methods for direct delivery of chemotherapy for treating brain tumors. Yale J Biol Med 2006, 79:141-152. 1994797, 17940624.